ANALYSIS ON POLICIES OF BIOSIMILAR MARKET IN CHINA
Author(s)
Zhang P1, Cui X2, Qian Y2
1Sanofi China, Shanghai, China, 2Sanofi China, Beijing, China
OBJECTIVES: This study aims to review released policies with regards to biosimilar products in China, and further understand the external environment that shapes the biosimilar market
Conference/Value in Health Info
2014-09, ISPOR Asia Pacific 2014, Beijing, China
Value in Health, Vol. 17, No. 7 (November 2014)
Code
PHP96
Topic
Health Policy & Regulatory
Topic Subcategory
Approval & Labeling
Disease
Multiple Diseases